Multidisciplinary Team Meetings 

A cancer multidisciplinary meeting (MDM) is where a team of health professionals meet to:

  • Review tests and scans

  • Consider all the treatment options and best practice guidelines

  • Make an individualised recommended treatment plan for each patient

 

Multidisciplinary meetings are attended by:

 

  • Surgeons

  • Medical oncologists

  • Radiation oncologists

  • Radiation therapists

  • Other specialist doctors: e.g. respiratory physician; palliative care doctors

  • Nurse specialists

  • Pathologists

  • Radiologists

  • Allied Health staff

  • Administration staff who assist with the meeting

The meetings are hosted by Latrobe Regional Hospital, with attendees from all Gippsland health services.

 

Multidisciplinary meetings currently held in Gippsland are:

  • Skin, Breast, Upper GI and Colorectal MDM

  • Lung MDM

  • Lymphoma MDM

  • Advanced Disease MDM (to discuss patients with metastatic disease)

  • Urology MDM

Links and further information

MDM Meeting Schedule
To view the Gippsland MDM Meetings Schedule for 2021, please click on the link:

MDM Meetings Schedule 2021

 

MDM Patient Information Brochure
MDM Consumer Information Brochures are available for you to provide to your patients prior to discussion by following this link:

MDM Patient Information Brochure

MDM Referrals
We are currently in the process of rolling out the QOOL VIC MDM software in Gippsland. Currently:

  • Referrals for Urology and Lymphoma MDMs should be made via QOOL VIC

  • Referrals to all other MDMs should be made through CANMAP

Key Contacts:

For further information on MDM Patient Referrals please contact:

 
GRICS Scholarship Program

The GRICS Scholarship Program is available to Gippsland health professionals who wish to further their professional development in cancer care. Applicants wishing to apply must ensure their preferred Continuing Professional Development activity supports one or more of the following priority areas:

  • Multidisciplinary Care;

  • Care Coordination;

  • Supportive Care; and

  • Reducing Unwanted Variation in Care.


GRICS Scholarship Program is available from 1 July until 30 June each financial year, subject to annual funding received from the Department of Health and approval from the GRICS Governance Committee.

 

 

Applicants who have applied for scholarship funding in previous years are welcome to again apply. Please note applications will not be accepted to fund the same activity applied for the previous year.

 

Completed forms can be submitted by one of the following means:

Mail: 

GRICS

Cancer Care Centre (Level 1)
Latrobe Regional Hospital
P O Box 424
TRARALGON VIC 3844

 

Fax: (03) 5173 8198

Email: gricswebsite@lrh.com.au 

 

For more information on the GRICS Scholarship Program please contact GRICS on 03 5128 0138.

 
Gippsland Cancer Service Mapping - Referral Pathways

GRICS have initiated the development of service maps to enhance cancer referral pathways for Clinicians and General Practitioners. These maps provide access information on services currently provided across Gippsland.  The pathways have been developed for each of the Gippsland chemotherapy sites – Bairnsdale Regional Health Service, Central Gippsland Health, Latrobe Regional Hospital, West Gippsland Healthcare Group and Gippsland Southern Health Service, with plans to extend the maps to other health services in our region.

 

The service maps contain information relating to which Physicians, Surgeons, Medical Oncologists, Radiation Oncologists, Day Oncology Units, Palliative Care and Cancer Care Nurses (where applicable) are appropriate for individual tumour streams.

 

To date GRICS have completed the Lung, Colorectal, Prostate, Oesophagogastric, Cervical, Breast, Pancreatic, Melanoma and Head and Neck cancer service maps with plans underway to develop pathways for additional tumour streams.  The PDF’s were updated in September 2020 and will continue to be updated as information and resources change.

 
 
Febrile Neutropenia and Immunotherapy Related Adverse Events
thermometer (5).png

Febrile Neutropenia

 

All patients presenting with fever following chemotherapy are at risk of neutropenic sepsis.

 

For management guidelines please refer to the EviQ website under Immediate Management of Neutropenic Fever. 

cancer.png

Immunotherapy Related Adverse Events (IRAES)

 

Immunotherapies used for cancer treatment are designed to elicit &/or amplify an immune response to help fight tumour growth and spread.

 

Immunotherapy can also cause the immune system to attack normal organs and tissue which can be associated with immune related adverse reactions that involve the lungs, intestines, liver, kidneys, hormone glands, and other organs, as well as infusion-related reactions.

 

Early diagnosis and appropriate management are essential to minimise these effects. For further information on IRAES on EviQ.

Supportive Care

Supportive care refers to services required by those affected or impacted by cancer.  It includes among other things information provision, symptom control, self-help and social support, psychological and spiritual support, rehabilitation, palliative care and bereavement care.  Supportive care activities in cancer can be broadly defined by the following five categories:

 

  • Physical needs;

  • Psychological needs;

  • Social needs;

  • Information needs; and

  • Spiritual needs.

Supportive care can be optimised through routine screening and follow-on referrals to appropriate treatment and care services. Members of the multidisciplinary team as well as family members, friends, support groups, volunteers and other community-based organisations can all play an important role in a cancer patients’ supportive care.

The Supportive Care Pathway

Benefits provided by Supportive Care for those affected by cancer include:

 

  • A positive impact on experiences of patients by reducing levels of anxiety and depression, better managing physical symptoms and increasing patient knowledge of the disease and treatment;

  • Improved medical outcomes through better adherence to treatment including faster recovery, fewer post-hospital complications, enhanced self-care and greater ability to cope with difficult treatments; and

  • Enhanced decision-making, active participation and care and improved patient satisfaction with care.

 

*Source: Department of Health, Victoria (2009): Providing optimal cancer care. Supportive care policy for Victoria.

 

Information on Supportive Care in Victoria is available by clicking on the following link:
WeCan – Cancer Supportive Care

Please visit the EVIQ website to access further education about supportive care:
https://education.eviq.org.au/courses/supportive-care
 

Supportive Care Screening Tool

The front page is for the patient to complete, including their signature.

Front Page

The front page is for the patient to complete, including their signature.

The K10 should be completed if the patient scores above four (4) on the distress thermometer. A ‘Staff Only’ section has been added for the staff member present at the time to complete.

Back Page

The K10 should be completed if the patient scores above four (4) on the distress thermometer. A ‘Staff Only’ section has been added for the staff member present at the time to complete.

General Practitioner Referral Letter
A GP Referral Letter is available. The form is designed to be completed on the computer, then printed and faxed off to the GP with a copy of the Supportive Care Screening Tool.
Please click on the image or the button below to open up the GP Referral Letter template.


 

General Practitioner Referral Letter

 
Clinical Trials

Clinical trials are an important way of testing the efficacy of new treatment options for cancer patients. Participation in a clinical trial is voluntary and open to anyone who meets the specified criteria outlined in the research protocol. Please note, some clinical trials can use exclusionary criteria such as age, gender, stage of disease or medical history when determining an applicants’ eligibility to participate in a clinical trial.

All clinical trials must be approved by a Victorian Human Research Ethics Committee before recruitment of volunteers can take place. The approvals process provides participants with assurances that:

 

  • Rights of cancer patients have been carefully considered in the research proposal; and

  • Benefits and risks have been rigorously tested against best-practice standards.

 

For more information on available clinical trial activity within Victoria please click on the following links:

The Victorian Clinical Trials Link

The Victorian Clinical Trials Link (VCTL) is a searchable portal of all cancer clinical trials in Victoria. It provides quick and easy access to cancer clinical trials for both clinicians and consumers. New and existing clinical trials are updated on the VCTL regularly by Cancer Council Victoria staff. The VCTL houses information about specific treatment intervention clinical trials that are being conducted in Victoria and available to patients, as well as general information and resources about clinical trials.

 

The VCTL comes in two forms; an app which is available to download for your Apple or Android phone and a website which can be accessed by visiting www.cancervic.org.au/trials

For general information on clinical trials operating in Australia please click on the following link:

 
 
Gippsland Data Requests 

Request Guidelines 
Stringent guidelines regarding the use and dissemination of this data apply.
GRICS receives cancer related data from the Victorian Department of Health and Human Services, Victorian Cancer
Registry and individual health service sites.


Requests for information held by GRICS will be evaluated against:

 

  • Department of Health and Human Services Conditions of Release of patient level data sets from the Victorian Health Information Reporting system (VHIRS) to the Victorian Integrated Cancer Services

  • Memorandum of Understanding – Integrated Cancer Services (GRICS effective 1st December 2018)

  • Victorian Cancer Registry Internet Portal (VCRIP) User Guide and Usage Policy for Notifiers & Users

  • Health Records Act 2001 (Vic) and |Health Privacy Principles |Health Privacy Principles |Privacy and Data Protection Act 2014 (Vic) and Information Privacy Principles, |Victorian Information Privacy Act (2000).

  • Privacy Act 1988

  • Latrobe Regional Hospital \ Health Information & Business Analysis \ Health Information [Policy]

  • Latrobe Regional Hospital \ Human Resources \ Human Resources (HR) [Policy]

Requests for information that include patient identified data will need ethics approval for ratification of release. The ethics application will need to be submitted by the requesting clinician, and data will not be released until the appropriate approval has been received from the relevant Ethics committee.

Every effort will be made to provide information in a timely manner. Current work practices take precedence. Time taken between request and provision will be monitored to assess impact on both GRICS staff and practitioner requests.
 

Links and further information

Inquiries to: Jody Neal | Cancer Data & Information Analyst 5128 0139
Mail to: Jody Neal | PO Box 424 Traralgon 3844 | Village Avenue Traralgon West
Email: jneal@lrh.com.au 

VIC_GOV_LOGO_clear.png

The Victorian Integrated Cancer Services are supported by the Victorian Government 

  • VICS YouTube Channel
  • Twitter
  • LinkedIn

Contact Us
 

GRICS
Level 1, Cancer Care Centre
Latrobe Regional Hospital
PO Box 424
Traralgon VIC 3844

Phone: (03) 5128 0138

Fax: (03) 5173 8198

Email: gricswebsite@lrh.com.au

© 2021 Gippsland Regional Integrated Cancer Service

The Victorian Integrated Cancer Services acknowledges Aboriginal and Torres Strait Islander people as the Traditional Custodians of the land and acknowledges and pays respect to their Elders, past and present.

We are committed to safe and inclusive work places, policies and services for people of LGBTIQ communities and their families.